Complement factors and reticular pseudodrusen in intermediate age-related macular degeneration staged by multimodal imaging
- PMID: 32509962
- PMCID: PMC7254108
- DOI: 10.1136/bmjophth-2019-000361
Complement factors and reticular pseudodrusen in intermediate age-related macular degeneration staged by multimodal imaging
Abstract
Objective: Systemic activation of the complement system in intermediate age-related macular degeneration (AMD) is understudied. Moreover, links between the presence of reticular pseudodrusen (RPD) and systemic complement dysregulation have not been studied. The aim of this study was to determine if there is a difference in plasma complement factor levels in intermediate AMD compared with controls, and if complement levels are related to the presence of RPD.
Methods and analysis: Levels of complement factors C1q (µg/mL), C4 (µg/mL), C2 (µg/mL), Mannose Binding Lectin (ng/mL), C4b (µg/mL), C3 (µg/mL), factor B (µg/mL), factor D (µg/mL), properdin (µg/mL), C3a (ng/mL), iC3b/C3b (ng/mL), Ba (ng/mL), factor H (µg/mL), factor I (µg/mL), C5 (µg/mL), C5a (pg/mL) and SC5b-9 (ng/mL) were measured in plasma.
Results: 109 cases and 65 controls were included in the study. Thirty-nine (36%) cases had RPD. Significantly lower systemic levels of: C1q (OR 0.96, 95% CI 0.94 to 0.98), factor B (OR 0.98, 95% CI 0.96 to 0.99), iC3b/C3b (OR 0.97, 95% CI 0.95 to 0.98), factor H (OR 0.99, 95% CI 0.98 to 0.99), factor I (OR 0.83, 95% CI 0.77 to 0.89) and C5 (OR 0.94, 95% CI 0.90 to 0.98) were found in cases versus controls. Significantly elevated levels of: C2 (OR 1.29, 95% CI 1.07 to 1.59), C3a (OR 1.03, 95% CI 1.01 to 1.05) Ba (OR 1.03, 95% CI 1.01 to 1.05) and C5a (OR 1.04, 95% CI 1.02 to 1.07) were found in cases versus controls. Systemic levels of complement factors measured were not related to the presence of RPD.
Conclusions: Levels of several systemic complement pathway factors were found to be altered in intermediate AMD. Systemic levels of complement factors were not related to RPD.
Keywords: epidemiology; immunology; inflammation; macula; retina.
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures

Similar articles
-
Complement Dysregulation in Obese Versus Nonobese Polycystic Ovary Syndrome Patients.Cells. 2023 Aug 4;12(15):2002. doi: 10.3390/cells12152002. Cells. 2023. PMID: 37566081 Free PMC article.
-
Association of imaging biomarkers and local activation of complement in aqueous humor of patients with early forms of age-related macular degeneration.Graefes Arch Clin Exp Ophthalmol. 2021 Mar;259(3):623-632. doi: 10.1007/s00417-020-04910-6. Epub 2020 Sep 2. Graefes Arch Clin Exp Ophthalmol. 2021. PMID: 32876798 Free PMC article.
-
Systemic complement activation in age-related macular degeneration.PLoS One. 2008 Jul 2;3(7):e2593. doi: 10.1371/journal.pone.0002593. PLoS One. 2008. PMID: 18596911 Free PMC article.
-
Association of risk genotypes of ARMS2/LOC387715 A69S and CFH Y402H with age-related macular degeneration with and without reticular pseudodrusen: a meta-analysis.Acta Ophthalmol. 2018 Mar;96(2):e105-e110. doi: 10.1111/aos.13494. Epub 2017 Jun 8. Acta Ophthalmol. 2018. PMID: 28593728 Review.
-
Reticular pseudodrusen: A critical phenotype in age-related macular degeneration.Prog Retin Eye Res. 2022 May;88:101017. doi: 10.1016/j.preteyeres.2021.101017. Epub 2021 Nov 6. Prog Retin Eye Res. 2022. PMID: 34752916 Review.
Cited by
-
Gender as an effect modifier in the relationship between hypertension and reticular pseudodrusen in patients with early or intermediate age-related macular degeneration.Int J Ophthalmol. 2022 Mar 18;15(3):461-465. doi: 10.18240/ijo.2022.03.14. eCollection 2022. Int J Ophthalmol. 2022. PMID: 35310058 Free PMC article.
-
Subretinal drusenoid deposits: An update.Taiwan J Ophthalmol. 2022 May 26;12(2):138-146. doi: 10.4103/tjo.tjo_18_22. eCollection 2022 Apr-Jun. Taiwan J Ophthalmol. 2022. PMID: 35813798 Free PMC article. Review.
-
Association of Systemic Inflammatory Factors with Progression to Advanced Age-related Macular Degeneration.Ophthalmic Epidemiol. 2022 Apr;29(2):139-148. doi: 10.1080/09286586.2021.1910314. Epub 2021 Apr 8. Ophthalmic Epidemiol. 2022. PMID: 33827374 Free PMC article.
-
Age-related macular degeneration and myeloproliferative neoplasms - A common pathway.Acta Ophthalmol. 2022 Oct;100 Suppl 271(Suppl 271):3-35. doi: 10.1111/aos.15247. Acta Ophthalmol. 2022. PMID: 36200281 Free PMC article.
-
Sex Differences in RANTES (CCL5) in Patients With Intermediate Age-Related Macular Degeneration (AMD) and Controls With no AMD.Transl Vis Sci Technol. 2022 Feb 1;11(2):12. doi: 10.1167/tvst.11.2.12. Transl Vis Sci Technol. 2022. PMID: 35133404 Free PMC article.
References
-
- Mimoun G, Soubrane G, Coscas G. [Macular drusen]. J Fr Ophtalmol 1990;13:511–30. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous